Clinical Trials
3 trialsNCT00421395 2021-08-16
Safety Study of NHL With 90Y-hLL2 IgG
Gilead Sciences
Phase 1/2 Completed
NCT00398372 2011-06-02
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment
Stanford University
Phase NA Completed
NCT00044902 2007-12-28
Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)
Amgen
Phase 2 Completed